Processing

Please wait...

Settings

Settings

Goto Application

1. WO2013003410 - PREVENTION AND TREATMENT OF HIV INFECTION

Publication Number WO/2013/003410
Publication Date 03.01.2013
International Application No. PCT/US2012/044315
International Filing Date 27.06.2012
IPC
A61K 35/14 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
14Blood; Artificial blood
A61K 35/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
A61P 31/18 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
18for HIV
A61P 31/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
CPC
A61K 35/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
14Blood; Artificial blood
A61P 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 31/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
18for HIV
Applicants
  • RONILU DEVELOPMENT CORPORATION [US]/[US] (AllExceptUS)
  • ESCOBAR-GAVIRIA, Roberto, De Jesus [CO]/[CO] (UsOnly)
  • ESCOBAR-URQUIJO, Nicolas, Enrique [CO]/[CO] (UsOnly)
  • RODRIGUEZ-SANCHEZ, Luis, Felipe [CO]/[US] (UsOnly)
Inventors
  • ESCOBAR-GAVIRIA, Roberto, De Jesus
  • ESCOBAR-URQUIJO, Nicolas, Enrique
  • RODRIGUEZ-SANCHEZ, Luis, Felipe
Agents
  • KIM, Stanley, A.
Priority Data
61/502,47529.06.2011US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) PREVENTION AND TREATMENT OF HIV INFECTION
(FR) PRÉVENTION ET TRAITEMENT D'INFECTION PAR LE VIH
Abstract
(EN)
A pharmaceutical composition for preventing and treating HIV infection includes an active ingredient made by a process involving a series of intra- and inter-species blood transfers made among male and female animals. The process modifies the components of blood in the animals such that the blood from the last animal in the series of transfers can be used as the active ingredient in a pharmaceutical composition which, when administered to an HIV-infected human subject, can eliminate any detectable HIV in the subject.
(FR)
L'invention concerne une composition pharmaceutique qui permet de prévenir et de traiter une infection par le VIH et qui comprend un principe actif obtenu par un procédé entraînant une série de transferts de sang parmi une espèce et entre des espèces effectués parmi des animaux mâles et femelles. Le procédé modifie les composants du sang chez les animaux de telle sorte que le sang provenant du dernier animal dans la série de transferts peut être utilisé en tant que principe actif dans une composition pharmaceutique qui, lorsqu'elle est administrée à un sujet humain infecté par le VIH, peut éliminer tout VIH détectable chez le sujet.
Other related publications
Latest bibliographic data on file with the International Bureau